Amgen bought ChemoCentryx ChemoCentryx from 10/20/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Amgen completed its acquisition of ChemoCentryx for $3.7 billion, or $52 per share.

ChemoCentryx

Review

Source:

{source} pictogram

investors.amgen.com

Vladimir Petenev

News editor

Write your comment first

News feed

Cian's 2022 revenue is up 37%

3/30/23 CIAN

MTS to relaunch speaker project with voice assistant

3/30/23 MTSS

Samolet has launched tokens for square footage in projects under construction

3/30/23 SMLT

MTS to launch flagship stores with smart home services

3/30/23 MTSS

China Mobile bought a stake in Postal Bank for $6.5 billion

3/30/23 941

Seligdar started selling gold on the Moscow Exchange

3/30/23 SELG

MTS gives up egg in the company logo

3/30/23 MTSS

Ozon plans to complete settlements with bondholders for $750 million in April

3/30/23 OZON

I.A. Likhachev Plant reported for 2022 according to RAS

3/29/23 ZILL

Nornickel will expand production in Finland

3/29/23 GMKN